Annual report
4503.TEDINET S100TNPZ
Period2023-04-01 → 2024-03-31
Filed2024-06-20
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.60T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.52T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.30T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.25T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.30T | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥25.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥133.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥25.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥132.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥156.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥145.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥245.3bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥17.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥98.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥124.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥120.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥195.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥17.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥98.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.57T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥2.46T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥2.33T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.27T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.32T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.97T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥948.6bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.60T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.51T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.46T | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.60T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.51T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.39T | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.29T | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥335.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥376.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥316.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥326.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥318.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥172.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥327.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥257.4bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥306.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥222.0bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥845.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥84.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥62.4bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥81.9bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥389.8bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | ¥614.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥195.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥216.3bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥229.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥181.1bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥9.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥54.24 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥67.08 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥64.93 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥104.15 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥9.47 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥54.09 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥67.05 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥64.9 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥104.08 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥890.07 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥839.26 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥799.26 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥748.03 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥694.03 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 44.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.0% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.7% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 1.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.7% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.0% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 15.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 14,754 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 14,484 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 14,522 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 15,455 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 15,883 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥688.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥613.6bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥542.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥545.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥600.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥194.0bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥130.6bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥373.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥338.2bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥270.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥223.4bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥293.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥333.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥348.1bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥292.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥314.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥225.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥193.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥240.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.46T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥1.49T | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥1.39T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.35T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.33T | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.28T | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥466.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.18T | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.02T | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥873.6bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥787.7bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥671.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥153.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥217.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥162.92 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.64 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.69 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.95 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.26 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥162.87 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥172.57 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥121.63 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥103.89 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥128.17 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥660 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥568.97 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥477.81 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥424.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥361.08 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 26.5% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.2% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 27.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 39.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,809,663,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,835,852,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,861,787,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,861,787,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,806 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 4,867 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 3,943 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,647 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 4,560 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceuticalreportable segment | employees | at 2024-03-31 | 14754 pure |
| Pharmaceuticalreportable segment | employees | at 2024-03-31 | 4806 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,686
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 3 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | 99000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | 99000000 | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | － | JPY |
| Monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | 99000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorAndIndependentDirectorMember | 6 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 68000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 68000000 | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 68000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | 72000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | 72000000 | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | － | JPY |
| Monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | 72000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00920-000OutsideDirectorWhoIsAnAuditAndSupervisoryCommitteeMember | 4 | |
| Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer | CurrentYearDuration_jpcrp030000-asr_E00920-000YasukawaKenjiMember | 309000000 | JPY |
| Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer | CurrentYearDuration_jpcrp030000-asr_E00920-000OkamuraNaokiMember | 461000000 | JPY |
| Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer | CurrentYearDuration_jpcrp030000-asr_E00920-000SugitaKatsuyoshiMember | 178000000 | JPY |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 14 | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 995000000 | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2340000000 | JPY |
| Number of issues whose number of shares decreased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 1 | |
| Total sale amount for decreased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares decreased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total sale amount for decreased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 4968367 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 4968367 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 1767000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 12311000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 727200 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 727200 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 574000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 415000000 | JPY |
| Revenue IFRS | Prior1YearDuration | 1518619000000 | JPY |
| Revenue IFRS | CurrentYearDuration | 1603672000000 | JPY |
| Cost of sales IFRS | Prior1YearDuration | 288353000000 | JPY |
| Cost of sales IFRS | CurrentYearDuration | 292485000000 | JPY |
| Gross profit IFRS | Prior1YearDuration | 1230266000000 | JPY |
| Gross profit IFRS | CurrentYearDuration | 1311187000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YearDuration | 630272000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYearDuration | 740110000000 | JPY |
| Research and development expenditure recognized as expense during period IFRS | Prior1YearDuration | 276128000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |